Back to News
Dec 1, 2025 8:00 AM

Juniper Biosciences Raises Oversubscribed and Upsized $40 Million Seed Financing to Fund Development of Its Innovative Pipeline

BRIDGEWATER, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Juniper Biosciences LLC today announced the closing of an oversubscribed and upsized $40 million seed financing through its parent company, Juniper Radiopharma LLC, co-led by NovaCapital, several high-net-worth individuals, and members of the Club Degli Investitori.

"We are thrilled to have the support of a diverse investor base who believe strongly in the promise that radiopharmaceuticals offer to the future of patient care." said Alex Agnoletto, CEO. "Our founding team brings deep expertise within global radiopharmaceutical development and manufacturing and is well positioned to advance our ...